ZyCoV-D

New Delhi: India’s first needleless COVID-19 vaccine ZyCov-D has been launched in Bihar’s Patna, according to reports. Manufactured by pharmaceutical company Zydus group, ZyCoV-D is a three-dose vaccine administered intradermally. The…

New Delhi: ZyCoV-D, which was cleared by the DCGI in August last year, has started supplying the first batch of the vaccine to the Union government, said the company. "We have started the supply of the three-dose ZyCoV-D to the…

Bhubaneswar: While Zycov-D, India’s first COVID-19 vaccine for those above 12, was approved by Drug Controller General, Director of Medical Education & Training (DMET) Dr CBK Mohanty said that the process to vaccinate above 12-year-old…

Bengaluru: India's drug regulator approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country. The company said…

New Delhi: Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to the office of Drug Controller General of India (DCGI) for ZyCoV-D. An approval for Zydus' vaccine, ZyCoV-D, would make it the…

New Delhi: The National Technical Advisory Group on Immunisation (NTAGI) chairman Dr NK Arora on Sunday said that the Covid-19 vaccine developed for children above the age of 12 years by pharmaceutical company Zydus Cadila will be available…